Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
18 01 2022
Historique:
pubmed: 19 10 2021
medline: 23 3 2022
entrez: 18 10 2021
Statut: ppublish

Résumé

Hospitalized patients are at risk of developing serious multidrug resistant bacterial infections. This risk is heightened in patients who are on mechanical ventilation, are immunocompromised, and/or have chronic comorbidities. We report the case of a 52-year-old critically ill patient with a multidrug resistant Acinetobacter baumannii (MDR-A) respiratory infection who was successfully treated with antibiotics and intravenous and nebulized bacteriophage therapy.

Identifiants

pubmed: 34662188
doi: 10.1128/AAC.00824-21
pmc: PMC8765271
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0082421

Références

Nat Microbiol. 2021 Feb;6(2):157-161
pubmed: 33432151
Antibiotics (Basel). 2020 May 09;9(5):
pubmed: 32397354
Virol Sin. 2019 Aug;34(4):347-357
pubmed: 31093881
J Intensive Care. 2015 Mar 02;3:9
pubmed: 27408726
Adv Drug Deliv Rev. 2018 Aug;133:76-86
pubmed: 30096336
Pharmaceuticals (Basel). 2021 Jan 05;14(1):
pubmed: 33466546
Am J Infect Control. 2009 Dec;37(10):783-805
pubmed: 20004811
Bacteriophage. 2012 Jul 1;2(3):159-167
pubmed: 23275867
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28807909
Nat Rev Drug Discov. 2003 Jun;2(6):489-97
pubmed: 12776223
J Trauma Acute Care Surg. 2018 Jul;85(1S Suppl 2):S18-S26
pubmed: 29370056
Clin Infect Dis. 2019 Nov 13;69(11):2015-2018
pubmed: 30869755

Auteurs

Sohail Rao (S)

DHR Health Institute for Research & Development, Edinburg, Texas, USA.
College of Pharmacy, University of Houston, Houston, Texas, USA.

Monica Betancourt-Garcia (M)

DHR Health Institute for Research & Development, Edinburg, Texas, USA.

Yetunde O Kare-Opaneye (YO)

DHR Health Institute for Research & Development, Edinburg, Texas, USA.

Brett E Swierczewski (BE)

Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.

Jason W Bennett (JW)

Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.

Bri'Anna Horne (B)

Adaptive Phage Therapeutics, Gaithersburg, Maryland, USA.

Joseph Fackler (J)

Adaptive Phage Therapeutics, Gaithersburg, Maryland, USA.

Lia Patricia Suazo Hernandez (LP)

DHR Health Institute for Research & Development, Edinburg, Texas, USA.

Michael J Brownstein (MJ)

Adaptive Phage Therapeutics, Gaithersburg, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH